ORLASKIN HYDRATING SUNSCREEN

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
ORLASKIN HYDRATING SUNSCREEN
Generic name
ORLASKIN HYDRATING SUNSCREEN
Manufacturer
Guangzhou Fantesy Biotechnology Co.,Ltd
Product type
HUMAN OTC DRUG
SPL set ID
0808b0cd-2cfb-8554-e063-6294a90ad6c4
SPL ID
479ede48-5b2e-5407-e063-6394a90aab53
Version
3
Effective date
2026-01-05
Source export date
2026-10-30
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-30/3b4c9bc1c064560160661a043b9878894ba805e5e90f4733fb76824b6ba7ac42/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run
20261102T182004Z
Imported at
2026-11-02 19:20:00
Harmonized routes table
Harmonized routes
CUTANEOUS

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with eyes , wear protective clothing , hats and eyewear when exposed to the sun . Avoid prolonged exposure in the sun. Keep out of reach of children. Do not use on damaged or brokenskin. Store in a cool , dry place and avoiddirect sunlight. If using with other sun protection products , consult with a doctor before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.